Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
125 Leser
Artikel bewerten:
(0)

Pre-Market Analysis on Life Technologies, Quest Diagnostics, Brookdale Senior Living, Antares Pharma, and Optimer Pharma

LONDON, April 12, 2013 /PRNewswire/ --

The Supreme Court, last year, upheld President Obama's Affordable Care Act (ACA), which is the biggest overhaul of the healthcare sector in decades. The ACA is expected to increase the number of insured individuals, which will benefit the sector. However, the reform is also expected to increase costs for the healthcare sector. Perhaps the biggest impact of the ACA in the near-term will be felt by medical instruments & supplies companies such as Antares Pharma Inc. (NASDAQ: ATRS) as they are required to pay a tax on gross sales. The ACA will also have a significant impact on medical laboratories & research companies such as Life Technologies Corp. (NASDAQ: LIFE), and Quest Diagnostics Inc. (NYSE: DGX), long-term care facilities providers such as Brookdale Senior Living Inc. (NYSE: BKD), and biotechnologies companies such as Optimer Pharmaceuticals Inc. (NASDAQ: OPTR). Healthcare stocks ended mostly higher on Thursday, tracking gains in the broad market. StockCall has posted free technical research on LIFE, DGX, BKD, ATRS, and OPTR which can be downloaded upon sign up at

http://www.stockcall.com/signup

Life Technologies Corp.'s shares edged higher yesterday. The stock closed 0.35% higher at $66.81 on above average volume of 3.58 million. Shares of LIFE have gained more than 2.20% in the last three trading sessions. The stock is currently trading close to its 52-week high of $67.92. Year-to-date, the stock has gained more than 36%, outperforming the broad market. Sign up and read the complimentary report on LIFE at

http://www.StockCall.com/LIFE041213.pdf

Shares of Quest Diagnostics Inc. rallied in trading on Thursday. The stock closed 4.42% higher at $59.83 on above average volume of 3.20 million. It also touched an intra-day high of $60 yesterday. Quest Diagnostics' shares have gained more than 5.60% in the last two sessions. The two-day rally has pushed the stock above its 50-day and 200-day moving averages, which is a bullish signal. The free report on DGX can be downloaded by signing up now at

http://www.StockCall.com/DGX041213.pdf

Shares of Brookdale Senior Living Inc. rose sharply yesterday, ending the day 2.21% higher at $28.20 on above average volume of 952,129. The stock touched an intra-day high of $28.33 in Thursday's session. The Long-Term Care Facility's shares have just moved above their 50-day moving average, which is a bullish signal. The upbeat trend is further confirmed by the stock's MACD chart. Free report on BKD can be accessed by registering at

http://www.StockCall.com/BKD041213.pdf

Shares of Antares Pharma Inc. edged higher in Thursday's session, extending its gains from the previous two trading sessions. The stock closed 1.42% higher at $3.57 on above average volume of 999,964, taking its gains in the last three sessions to nearly 3.50%. Despite the recent gains, Antares Pharma's shares have fallen 6.30% so far in 2013. The stock is currently trading more than 36% below its 52-week high. Register with StockCall and download the research on ATRS for free at

http://www.StockCall.com/ATRS041213.pdf

Shares of Optimer Pharmaceuticals Inc. rose in trading yesterday; however, the gains were limited. The stock closed 0.34% higher at $14.83 on volume of 429,780. The biotech company's shares have had an excellent run so far in 2013, gaining nearly 64%. The stock is currently trading well above its 50-day and 200-day moving averages. Read the full free research on OPTR by signing up to StockCall at

http://www.StockCall.com/OPTR041213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.